Goldman Sachs
GNPX icon

Goldman Sachs’s Genprex GNPX Stock Holding History

Goldman Sachs’s Portfolio GNPX Stock Details GNPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-24
Closed -$22.5K – 6200
2024
Q4 		$22.5K Buy
+24
New +$31.5K ﹤0.01% 5891
2022
Q3 		– Hold
0
– -$30K – 6380
2022
Q2 		– Sell
-3
Closed -$211K – 6123
2022
Q1 		$275K Buy
3
+2
+200% +$195K ﹤0.01% 5710
2021
Q4 		$29K Buy
+1
New +$83.4K ﹤0.01% 6329
2021
Q3 		– Sell
-1
Closed -$86K – 6332
2021
Q2 		$86K Buy
+1
New +$164K ﹤0.01% 5974
2021
Q1 		– Hold
0
– – – 5875
2020
Q4 		– Hold
0
– -$46K – 5567
2020
Q3 		– Sell
-1
Closed -$158K – 5200
2020
Q2 		$134K Buy
+1
New +$122K ﹤0.01% 4913
2019
Q4 		– Sell
-1
Closed -$21K – 5291
2019
Q3 		$21K Buy
+1
New +$42.2K ﹤0.01% 5108

Other funds holding GNPX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HIP
HUB Investment Partners Austin, Texas $4.18B AUM 24.76% 1-Year Est. Return
CCM
Corsair Capital Management New York $673M AUM 109.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Goldman Sachs's GNPX Position: Q1 2025 in Review

Goldman Sachs sold out of Genprex (GNPX) in Q1 2025, closing a stake of 24 shares — an estimated $22.5K sold.

Goldman Sachs first reported a position in GNPX in Q3 2019 and held it in 6 quarters. The position peaked at $275K in Q1 2022. 14 funds tracked by Wall St. Rank hold GNPX as of Q1 2025.

  • Goldman Sachs reported no remaining Genprex position as of Q1 2025 after selling out during the quarter.
  • Goldman Sachs sold 24 Genprex shares in Q1 2025, an estimated $22.5K.
  • Goldman Sachs first reported a position in Genprex in Q3 2019 and held it in 6 quarters.
  • Goldman Sachs's Genprex position peaked at $275K in Q1 2022.
  • 14 funds tracked by Wall St. Rank held Genprex as of Q1 2025.

Based on Goldman Sachs's 13F filing for Q1 2025, filed 9 May 2025.